Showing results (271-280 of 290) with videos related to

Sort By:
Pageof 29
Rheumatology (Oxford, England)|March 22, 2008
Sensitivity and specificity of autoantibodies binding to citrullinated carboxyterminal telopeptides of types I and II collagens in an early arthritis seriesM-K Koivula, E Savolainen, O Kaipiainen-Seppänen, et al.
Calcified Tissue International|February 20, 2007
Genetic and constitutional influences on bone turnover markers: a study of male twin pairsO S Donescu, M C Battié, J Kaprio, et al.
American Journal of Veterinary Research|August 18, 1999
Diurnal variation in concentrations of various markers of bone metabolism in dogsA Liesegang, R Reutter, M L Sassi, et al.
Acta Anaesthesiologica Scandinavica|September 10, 2013
Serum markers of collagen synthesis and degradation in acute respiratory failure patientsM Okkonen, F Gäddnäs, V Pettilä, et al.
Parasitology Research|October 10, 1998
The level of the collagen cross-link pyridinoline reflects the improvement of cutaneous lesions in one case of skin alveolar echinococcosisS Ricard-Blum, S Bresson-Hadni, P Grenard, et al.
Archives of Disease in Childhood|August 26, 2003
Radiological and biochemical resolution of nutritional rickets with calciumL M Oginni, C A Sharp, O S Badru, et al.
Acta Physiologica Scandinavica|March 22, 2003
Synthesis and degradation of type IV collagen in rat skeletal muscle during immobilization in shortened and lengthened positionsA M Ahtikoski, S O A Koskinen, P Virtanen, et al.
The European Respiratory Journal|October 30, 1999
Carboxyterminal propeptide of type I procollagen in ELF: elevation in asbestosis, but not in pleural plaque diseaseL Lammi, L Ryhänen, E Lakari, et al.
Molecular Microbiology|August 1, 1990
Type V collagen as the target for type-3 fimbriae, enterobacterial adherence organellesA M Tarkkanen, B L Allen, B Westerlund, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancerS Ylisirniö, M Höyhtyä, R Mäkitaro, et al.
Pageof 29